Literature DB >> 34137221

Primary cilium and its role in tumorigenesis.

Hongmei Mao1, Yi Sun1.   

Abstract

The primary cilium, a sensory organelle that protrudes from the surface of most eukaryotic cells, receives and transduces various critical signals that are essential for normal development and homeostasis. Structural or functional disruption of primary cilia causes a number of human diseases, including cancer. Primary cilia has cross talks with cell cycle and it may act as a cell cycle checkpoint to suppress cancer development. Moreover, primary cilia has cross-regulation with autophagy, which may affect tumor progression. We then discuss the association of the primary cilia with several oncogenic signaling pathways, including Shh, Wnt, Notch and platelet-derived growth factor receptor (PDGFR). Since these signaling pathways are often over-activated in many types of human cancers, primary cilia are likely to play a role in the tumorigenesis by modulating these pathways. Finally, we summarize current progress on the role of cilia during tumorigenesis and the challenges that the cilia-cancer field faces.

Entities:  

Keywords:  Autophagy; Cell cycle; Cilia-related signaling pathways; Primary cilia; Tumorigenesis

Mesh:

Year:  2021        PMID: 34137221      PMCID: PMC8710278          DOI: 10.3724/zdxbyxb-2021-0048

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  170 in total

Review 1.  The primary cilium: keeper of the key to cell division.

Authors:  Junmin Pan; William Snell
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

2.  Reciprocal regulation of cilia and autophagy via the MTOR and proteasome pathways.

Authors:  Shixuan Wang; Man J Livingston; Yunchao Su; Zheng Dong
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

3.  Platelet-derived growth factor receptor-alpha in ventricular zone cells and in developing neurons.

Authors:  J Andrae; I Hansson; G B Afink; M Nistér
Journal:  Mol Cell Neurosci       Date:  2001-06       Impact factor: 4.314

Review 4.  Architecture of the IFT ciliary trafficking machinery and interplay between its components.

Authors:  Kazuhisa Nakayama; Yohei Katoh
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-05-26       Impact factor: 8.250

5.  Tumor-driven paracrine platelet-derived growth factor receptor alpha signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma.

Authors:  Max L Tejada; Lanlan Yu; Jianying Dong; Kenneth Jung; Gloria Meng; Franklin V Peale; Gretchen D Frantz; Linda Hall; XiaoHuan Liang; Hans-Peter Gerber; Napoleone Ferrara
Journal:  Clin Cancer Res       Date:  2006-05-01       Impact factor: 12.531

6.  The major alpha-tubulin K40 acetyltransferase alphaTAT1 promotes rapid ciliogenesis and efficient mechanosensation.

Authors:  Toshinobu Shida; Juan G Cueva; Zhenjie Xu; Miriam B Goodman; Maxence V Nachury
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-10       Impact factor: 11.205

7.  Expression pattern of Motch, a mouse homolog of Drosophila Notch, suggests an important role in early postimplantation mouse development.

Authors:  F F Del Amo; D E Smith; P J Swiatek; M Gendron-Maguire; R J Greenspan; A P McMahon; T Gridley
Journal:  Development       Date:  1992-07       Impact factor: 6.868

8.  Arl13b regulates ciliogenesis and the dynamic localization of Shh signaling proteins.

Authors:  Christine E Larkins; Gladys D Gonzalez Aviles; Michael P East; Richard A Kahn; Tamara Caspary
Journal:  Mol Biol Cell       Date:  2011-10-05       Impact factor: 4.138

9.  A Presenilin-2-ARF4 trafficking axis modulates Notch signaling during epidermal differentiation.

Authors:  Ellen J Ezratty; H Amalia Pasolli; Elaine Fuchs
Journal:  J Cell Biol       Date:  2016-06-27       Impact factor: 10.539

10.  Activation of the hedgehog pathway in advanced prostate cancer.

Authors:  Tao Sheng; Chengxin Li; Xiaoli Zhang; Sumin Chi; Nonggao He; Kai Chen; Frank McCormick; Zoran Gatalica; Jingwu Xie
Journal:  Mol Cancer       Date:  2004-10-13       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.